Wistar scientists characterized an inhibitor that targets acetate metabolism in cancer cells. This molecule caused tumor growth inhibition and regression in preclinical studies, demonstrating the promise of this approach as a novel therapeutic strategy for solid tumors. Credit: The Wistar Institute


Alternative cancer cell fuel source targeted as therapeutic approach for breast cancer


Leave A Reply